Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Enveric Biosciences Inc (ENVB)

Enveric Biosciences Inc (ENVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Enveric Biosciences Inc 4851 TAMIAMI TRAIL N SUITE 200 NAPLES FL 34103 USA

www.enveric.com Employees: 7 P: 239-302-1707

Description:

Enveric Biosciences Inc. is a patient-centric biotechnology company endeavoring to enhance the lives of Cancer Treatments with novel cannabinoid medicines. Enveric Biosciences Inc., formerly known as AMERI Holdings Inc., is based in NAPLES, Fla.

Key Statistics

Overview:

Market Capitalization, $K 3,305
Enterprise Value, $K 1,015
Shares Outstanding, K 10,170
Annual Sales, $ 0 K
Annual Net Income, $ -17,290 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,080 K
EBIT, $ -8,500 K
EBITDA, $ -8,090 K
60-Month Beta 0.68
% of Insider Shareholders 1.20%
% of Institutional Shareholders 13.82%
Float, K 10,048
% Float 98.80%
Short Volume Ratio 0.57

Growth:

1-Year Return -75.93%
3-Year Return -99.39%
5-Year Return -99.93%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 99.76%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.24 on 11/14/24
Next Earnings Date 11/18/24
Earnings Per Share ttm -2.56
EPS Growth vs. Prev Qtr 4.00%
EPS Growth vs. Prev Year 81.54%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-50 on 07/15/22

ENVB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -221.55%
Return-on-Assets % -164.32%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.74
Book Value/Share 0.44
Interest Coverage -0.95
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar